Detalhe da pesquisa
1.
Results of a Dose-Finding Phase 1b Study of Subcutaneous Atezolizumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer.
Clin Pharmacol Drug Dev
; 10(10): 1142-1155, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33788415